American Society of Bone and Mineral Research 2012

In this review:

Anti-sclerostin antibody AMG 785
Odanacatib improves BMD
BMD changes and fracture prediction
Antihypertensive drugs and hip fracture risk
Non-benzodiazepine hypnotics and hip fracture risk
Duration and safety of osteoporosis therapy
Osteocalcin regulates bone formation via the CNS
Denosumab + teriparatide improve BMD
Calcium supplements and CV disease risk
Oestrogen deficiency mediates bone loss in hypogonadal men
Bone loss after bariatric surgery

Please login below to download this issue (PDF)